[{"address1": "2929 7th Street", "address2": "Suite 105", "city": "Berkeley", "state": "CA", "zip": "94710", "country": "United States", "phone": "510 982 6030", "website": "https://cariboubio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies in the United States and internationally. Its lead product candidate is CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma. The company also develops CB-011, an allogeneic anti-BCMA CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma; and CB-012, an allogeneic anti-CD371 CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory acute myeloid leukemia. Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California.", "fullTimeEmployees": 158, "companyOfficers": [{"maxAge": 1, "name": "Dr. Rachel E. Haurwitz Ph.D.", "age": 38, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1986, "fiscalYear": 2023, "totalPay": 979083, "exercisedValue": 0, "unexercisedValue": 486940}, {"maxAge": 1, "name": "Dr. Steven B. Kanner Ph.D.", "age": 65, "title": "Chief Scientific Officer", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 669310, "exercisedValue": 0, "unexercisedValue": 447452}, {"maxAge": 1, "name": "Ms. Barbara G. McClung Esq., J.D.", "age": 69, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1955, "fiscalYear": 2023, "totalPay": 669310, "exercisedValue": 0, "unexercisedValue": 402144}, {"maxAge": 1, "name": "Mr. Sriram  Ryali M.B.A.", "age": 42, "title": "Chief Financial Officer", "yearBorn": 1982, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Poon", "title": "Vice President of Operations & Information Technology", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ryan  Fischesser", "title": "Interim Principal Accounting Officer & Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Timothy P. Kelly M.B.A.", "age": 55, "title": "Chief Technology Officer", "yearBorn": 1969, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Amy  Figueroa C.F.A.", "title": "Vice President of Investor Relations & Corporate Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Reigin  Zawadzki", "title": "Chief People Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Ruhi A. Khan M.B.A.", "age": 49, "title": "Chief Business Officer", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 573900, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 5, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.41, "open": 1.42, "dayLow": 1.3, "dayHigh": 1.425, "regularMarketPreviousClose": 1.41, "regularMarketOpen": 1.42, "regularMarketDayLow": 1.3, "regularMarketDayHigh": 1.425, "payoutRatio": 0.0, "beta": 2.314, "forwardPE": -0.6582914, "volume": 777718, "regularMarketVolume": 777165, "averageVolume": 1442815, "averageVolume10days": 976450, "averageDailyVolume10Day": 976450, "bid": 1.28, "ask": 1.34, "bidSize": 1, "askSize": 2, "marketCap": 118624040, "fiftyTwoWeekLow": 1.22, "fiftyTwoWeekHigh": 8.33, "priceToSalesTrailing12Months": 10.337607, "fiftyDayAverage": 1.6108, "twoHundredDayAverage": 2.05535, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -73857712, "profitMargins": 0.0, "floatShares": 81561711, "sharesOutstanding": 90552704, "sharesShort": 8858817, "sharesShortPriorMonth": 9535766, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.097799994, "heldPercentInsiders": 0.10037, "heldPercentInstitutions": 0.63288, "shortRatio": 5.35, "shortPercentOfFloat": 0.1025, "impliedSharesOutstanding": 90552704, "bookValue": 3.105, "priceToBook": 0.42190015, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -148120000, "trailingEps": -1.66, "forwardEps": -1.99, "enterpriseToRevenue": -6.436, "enterpriseToEbitda": 0.468, "52WeekChange": -0.79682994, "SandP52WeekChange": 0.2021538, "quoteType": "EQUITY", "currentPrice": 1.31, "targetHighPrice": 34.0, "targetLowPrice": 3.0, "targetMeanPrice": 13.25, "targetMedianPrice": 10.5, "recommendationKey": "none", "numberOfAnalystOpinions": 8, "totalCash": 228178000, "totalCashPerShare": 2.52, "ebitda": -157800000, "totalDebt": 26641000, "quickRatio": 7.178, "currentRatio": 7.383, "totalRevenue": 11475000, "debtToEquity": 9.474, "revenuePerShare": 0.128, "returnOnAssets": -0.25142, "returnOnEquity": -0.43598998, "grossProfits": -119493000, "freeCashflow": -78726872, "operatingCashflow": -124109000, "revenueGrowth": -0.914, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -16.66897, "financialCurrency": "USD", "symbol": "CRBU", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NMS", "gmtOffSetMilliseconds": -18000000, "esgPopulated": false, "messageBoardId": "finmb_272189231", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "market": "us_market", "regularMarketChangePercent": -7.0922003, "regularMarketPrice": 1.31, "shortName": "Caribou Biosciences, Inc.", "longName": "Caribou Biosciences, Inc.", "marketState": "POST", "corporateActions": [], "postMarketTime": 1740171606, "regularMarketTime": 1740171601, "epsTrailingTwelveMonths": -1.66, "epsForward": -1.99, "epsCurrentYear": -1.69905, "priceEpsCurrentYear": -0.7710191, "fiftyDayAverageChange": -0.30080009, "fiftyDayAverageChangePercent": -0.18673956, "twoHundredDayAverageChange": -0.7453501, "twoHundredDayAverageChangePercent": -0.362639, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-23", "postMarketChangePercent": 0.3831414, "postMarketPrice": 1.31, "postMarketChange": 0.004999995, "regularMarketChange": -0.100000024, "regularMarketDayRange": "1.3 - 1.425", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1442815, "fiftyTwoWeekLowChange": 0.089999914, "fiftyTwoWeekLowChangePercent": 0.07377042, "fiftyTwoWeekRange": "1.22 - 8.33", "fiftyTwoWeekHighChange": -7.02, "fiftyTwoWeekHighChangePercent": -0.8427371, "fiftyTwoWeekChangePercent": -79.68299, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1627047000000, "displayName": "Caribou Biosciences", "trailingPegRatio": null, "__fetch_time": "2025-02-21"}]